The Effect of Ultra Short Wave Assisted Treatment on Adult Patients with Mycoplasma Pneumonia
Objective To explore the application effect of ultra short wave adjuvant therapy in patients with Myco-plasma pneumonia.Methods A total of 80 adult patients with mycoplasma pneumonia who received treatment in Shan-dong Health Group Xinwen Central hospital from June 2019 to September 2023 were randomly selected as the study objects,and were divided into control group(n=40)receiving conventional treatment and observation group(n=40)re-ceiving conventional treatment according to random coin-operated method.The clinical symptom resolution time,lung function,inflammatory factor level and coagulation function were compared between the two groups.Results Fever re-mission time,cough remission time,sputum remission time,lung rales disappearance time and chest radiographic le-sion absorption time in observation group were shorter than those in control group,the differences were statistically significant(all P<0.05).After 14 days of treatment,the maximum respiratory flow rate was(190.23±5.57)L/min,forced expiratory volume was(2.49±0.32)L at the end of the first second and forced vital capacity was(2.77±0.53)L in the observation group,which were higher than those in the control group,the differences were statistically signifi-cant(t=9.419,4.605,5.219,all P<0.05);after 14 days of treatment,tumor necrosis factor-α was(17.58±3.06)ng/L,procalcitonin was(0.64±0.13)ng/L,interleukin-6 was(28.87±3.51)pg/mL and C-reactive protein was(10.74±1.76)mg/L in observation group,which were lower than those in control group,the differences were statistically signifi-cant(t=4.684,8.705,8.308,4.459,all P<0.05).After 14 days of treatment,the platelet count was(201.31±42.16)×105/L and D-dimer was(0.51±0.13)mg/L in observation group,which were lower than those in control group,and the differences were statistically significant(t=2.679,7.339,both P<0.05).Conclusion Ultrashort wave adjuvant therapy can reduce the level of inflammatory factors in adult patients with mycoplasma pneumonia,improve lung function and blood circulation,and shorten the time of clinical symptoms.
Ultra short waveMycoplasma pneumoniaLung functionInflammatory factorsAdjuvant therapy